IRVINE, Calif., Oct. 4, 2018 /PRNewswire/ -- MedISAO, a leading Information Sharing and Analysis Organization dedicated
MedISAO, in conjunction with the FDA and NH-ISAC, is working to create a community that encourages and supports the sharing of information regarding medical device cybersecurity vulnerabilities. These vulnerabilities, if exploited, may compromise a medical device's efficacy and potentially endanger healthcare IT infrastructures and patient safety. The FDA considers participation in an ISAO a critical component for a manufacturer to manage these threats.
"The FDA has made it very clear that cybersecurity is a major concern," said Daniel Beard, Director, MedISAO. "Manufacturers are not only expected to make cybersecurity part of their design and development, but they are also expected to monitor for vulnerabilities post-market. MedISAO can help by providing a community dedicated to keeping medical devices secure. We are happy to work together with the FDA towards that goal."
"Besides satisfying a key component of FDA's Guidance on Postmarket Cybersecurity, membership in MedISAO grants members access to a coordinated vulnerability disclosure program and an automatic reporting form," said Beard. "Membership can help avoid costly correction reporting when vulnerabilities are discovered as well as provide access to training materials and security tools. Ultimately we are working together to reduce patient harm while increasing privacy and security for everyone."
MedISAO, a division of Promenade Software, Inc., is an organization composed of members of the medical device community that is dedicated to improving the security of medical devices through education, awareness and advocacy. MedISAO provides cybersecurity information, education and tools tailor-made for the medical device industry. MedISAO is a registered ISAO providing compliance with the FDA's recommendation in the Postmarket Management of Cybersecurity in Medical Devices.
For more information, visit www.medisao.com and www.promenadesoftware.com
FDA MOU can be found here: https://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/OtherMOUs/ucm622056.htm
MedISAO Matt Weiss 949 329-8570 firstname.lastname@example.org www.medisao.com
View original content:http://www.prnewswire.com/news-releases/medisao-enters-mou-with-the-us-fda-and-nh-isac-300724460.html
Subscribe to our Free Newsletters!
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...View All